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Abstract
The advent of the single cell sequencing era opens new avenues for the personalized
treatment. The first but important step is to discover the subject heterogeneity at the
single cell resolution. In this article, we address the two-level-clustering problem of
simultaneous subject subgroup discovery (subject level) and cell type detection (cell level)
based on the scRNA-seq data from multiple subjects. However, the current statistical
approaches either cluster cells without considering the subject heterogeneity or group
subjects not using the single-cell information. To overcome the challenges and fill the
gap between cell clustering and subject grouping, we develop a solid nonparametric
Bayesian model SCSC (Subject and Cell clustering for Single-Cell expression data) to
achieve subject and cell grouping at the same time. SCSC does not need to prespecify
the subject subgroup number or the cell type number, automatically induces subject
subgroup structures and matches cell types across subjects, and directly models the
scRNA-seq raw count data by deliberately considering the data’s dropouts, library sizes,
and over-dispersion. A computationally efficient blocked Gibbs sampler is proposed
for the posterior inference. The simulation and the application to a multi-subject
iPSC scRNA-seq dataset validate the function of SCSC to discover subject and cell
heterogeneity.
Keywords: High-throughput single-cell genomic data; Nonparametric Bayes; Mixture of
mixtures; Nonignorable dropout mechanism; Markov chain Monte Carlo.
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1 Introduction
The fast advancement in the single cell technology has enabled the expression profiling for
thousands of cells simultaneously, resulting in rich accumulations of the single cell RNA-seq
(scRNA-seq) data in the public databases, for example, the Gene Expression Omnibus (Edgar
et al., 2002), the Human Cell Atlas (Rozenblatt-Rosen et al., 2017). Integrating the scRNA-seq
data from multiple subjects gives rise to unprecedented opportunities to analyze and investigate
the subject heterogeneity at the single cell resolution. The subject heterogeneity is referred to
as the human race subpopulations, the patient disease subtypes, or other differentiable human
biological characteristics according to different contexts. Using the disease subtypes as an
illustration, previous biological studies have found differences in tumor cell proportions among
subtypes of breast cancers (Makki, 2015), lung cancers (Busch et al., 2016) and other diseases.
The subtle observations can be captured by the scRNA-seq data but may be missed using
the traditional expression data from microarray or bulk RNA-seq, which are the aggregated
expression signals from diverse cell types. As a result, there is an urgent need to employ the
scRNA-seq data to tease apart the cellular heterogeneity and obtain insights into the subject
heterogeneity.
Specifically, we formulate the subject and cell heterogeneity discovery problem as a two-
level clustering statistical problem by directly modeling the multi-subject scRNA-seq data,
which are demonstrated in Figure 1(a). The Figure 1(b) displays an artificial demonstration
of the two-level clustering. At the cell level, the cells having similar expression values are
clustered together. At the subject level, the subjects having similar cellular distributions are
grouped. Two subjects are said to have the same cellular distributions if they share the cell
type proportions and the expression levels for each cell type. In addition, to obtain valid
biological results, we need to match the cell types across subjects by considering the effects
caused by the subject subgroups (Figure 1(b)). We notice that our two-level clustering problem
is different from the bi-clustering (Cheng and Church, 2000; Turner et al., 2005; Prelic et al.,
2006) which groups subjects and genes using the aggregated expression data matrix.
However, analyzing the scRNA-seq data suffers from several statistical challenges. First,
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Figure 1: An artificial illustration of the data structure and the study goal. (a) The data
structure of the multi-subject scRNA-seq data. One subject corresponds to a count data
matrix. In the matrix, each column is a cell and each row is a gene. The gene number G
keeps the same across subjects, while the cell number varies from one subject to another. (b)
Based on the count data matrices, our study aims to identify subject subgroups at the subject
level and cluster cells at the cell level. In subgroup 1, there are 70% cell type 1 in green
triangles and 30% cell type 2 in blue dots. Compared to subgroup 1, the cellular distribution
in subgroup 2 can change in two ways, the cell proportions and the cell locations. For a good
visualization, only two gene dimensions are illustrated (expression in log scale). The brown
and purple arrows represent the subgroup 2 and 3 effects, respectively, when the subgroup 1 is
treated as a reference.
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the scRNA-seq data are read counts and reveal over-dispersion. The conventional normal or
Poisson distribution assumption does not apply to the scRNA-seq data. Second, in contrast
to bulk RNA-seq data, the scRNA-seq counts have a relatively large proportion of zeros.
This zero-inflation phenomenon, also called dropouts, is mainly caused by a low amount of
mRNA molecules in one cell, so the expression levels on some genes are hard to surpass the
measurable threshold, thus leading to the zero values. The dropout rate of one cell relies on
the corresponding library size and the underlying true expression level of each gene (Jia et al.,
2017). Therefore, modeling the dropout events plays a crucial role in correctly analyzing the
scRNA-seq data. See Figure 1(a) for a cartoon illustration for the multi-subject scRNA-seq
data structure.
There has been a large number of statistical literature working on cell clustering within
one subject. They can be classified as three categories: direct clustering, dimension reduction
followed by clustering, and imputation followed by clustering. The direct clustering methods
model the heterogeneous scRNA-seq data via the latent variable model (Buettner et al., 2015),
the hierarchical clustering (Yau et al., 2016), the consensus approach that integrates results
from multiple clustering techniques (Kiselev et al., 2017), or the mixture models (Prabhakaran
et al., 2016; Sun et al., 2017; Song et al., 2019; Liu et al., 2019). Recently, some fast clustering
approaches were developed, which are tractable on ultra-large datasets (Ntranos et al., 2016;
Sinha et al., 2018; Lopez et al., 2018). The dimension reduction methods include the classical
approaches PCA, tSNE (Der Maaten and Hinton, 2008), as well as approaches specially
designed for scRNA-seq, such as the zero-inflated factor analysis (ZIFA) (Pierson and Yau,
2015), ZINB-WaVE (Risso et al., 2018), and UMAP (Becht et al., 2019). Next, clustering
is conducted in the low-dimension latent space. The zero-imputation approaches (Lin et al.,
2017; Van Dijk et al., 2017; Huang et al., 2018; Zhang and Zhang, 2018) first impute the excess
zeros and then carry out clustering on the imputed data. Nevertheless, when applied to the
multi-subject scRNA-seq data, all the methods do not consider the subject heterogeneity and
ignore the fact that the gene expression levels can change with subjects, thus possibly leading
to incorrect cell clustering results.
On the other hand, a plethora of statistical models is proposed to cluster subjects based
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on the aggregated expression matrix with genes in row and subjects in column, where the
expression vector of one subject can be viewed as the row sums of the subject’s gene-cell
expression matrix in Figure 1(a). Pan and Shen (2007) adopted a normal mixture model
and developed an L1-penalized expectation-maximization algorithm to distinguish subjects
and detect differentially expressed (DE) genes. Wang and Zhu (2008) instead used the L∞
and hierarchical penalties to refine the clustering results. The sparse K-means proposed by
Witten and Tibshirani (2010) simultaneously extracted a few DE genes and grouped subjects
by maximizing weighted between-cluster sum-of-squares. Huo et al. (2016) subsequently
generalized the sparse K-means to the expression data from multiple studies. Later, Luo and
Wei (2019) proposed a more efficient and flexible Bayesian framework to conduct integrative
subject clustering. The bi-clustering techniques (Cheng and Church, 2000; Turner et al., 2005;
Prelic et al., 2006) achieved subject clustering and feature allocation, where each subject
corresponds to a data vector. Therefore, when one subject corresponds to a data matrix as in
our case, the subject-clustering methods fail to be applicable.
Moreover, most methods mentioned above require a predetermination of the cluster number
and need to try multiple choices, which may be practically difficult and computationally
expensive. The nonparametric Bayesian prior—Dirichlet process (DP) (Ferguson, 1973; Sethu-
raman, 1991)—is well-known for its flexibility of automatically selecting the cluster number in
a data-driven manner. However, the DP only addresses one-level clustering, which motivates
two extensions—the hierarchical DP (HDP) (Teh et al., 2006) and the nested DP (NDP)
(Rodriguez et al., 2008)—that are close to our two-level clustering problem. Unfortunately,
using the terms in our context, the HDP assigns a cell mixture distribution to each subject
but with different mixture weights, so the subjects cannot form a group structure. Although
NDP promotes the subject group structure, subjects in different groups do not share the cell
components, which causes difficulty in matching cell types across subjects.
To the best of our knowledge, there is no statistical approach to simultaneously tackle the
subject and cell clustering on the multi-subject scRNA-seq data. For the two-level clustering
part, we develop a novel nonparametric Bayesian prior that hybridizes the advantages of HDP
and NDP, inducing shared components for cells and group structures for subjects. For the data
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modeling part, we take advantage of the zero-inflated Poisson-log-normal (ZIPLN) distribution
with a Probit dropout mechanism, which accounts for zero-inflation, over-dispersion, and count
nature of scRNA-seq data. Integrating the nonparametric Bayesian prior with the ZIPLN
distribution arrives at our model SCSC that enables simultaneous subject and cell clustering
for the scRNA-seq raw count data and does not require any specification for the subject or cell
cluster number in advance. For the posterior inference of SCSC, we design an efficient blocked
Gibbs sampler (Ishwaran and James, 2001) based on an approximation model to SCSC. The
approximation accuracy is guaranteed theoretically as long as the model truncation numbers
and related parameters are appropriately chosen.
We organize our paper as follows. Section 2 presents a brief review of DP and its two
extensions, HDP and NDP, which motivates us to propose a hybrid nonparametric Bayesian
prior enjoying the strengths of HDP and NDP. In Section 3, we develop the SCSC model that is
built upon the hybrid prior and tailored to the scRNA-seq data. An efficient posterior sampling
scheme for SCSC is discussed and provided in Section 4, and its application to synthetic data
and real world data is illustrated in Section 5. We end our paper with a discussion in Section
6.
2 Preliminaries on Nonparametric Priors
Suppose that the scRNA-seq data are collected for m subjects with subject j having nj
sequenced cells in some tissue, and in each cell the expression levels for G genes are measured.
We denote by X
(j)
gi the observed read count mapped to gene g in cell i for subject j. All the
read counts for subject j can be wrapped up using a data matrix X(j) with G genes in row
and nj cells in column. To describe the subject heterogeneity, we assume that subjects can
be separated to form several subgroups, where subjects in the same subgroup enjoy similar
characteristics and subjects in different subgroups have distinct features. We use S(j) to
represent which subgroup subject j belongs to. Similarly, the cell heterogeneity is characterized
by cell types, and the cell type of cell i for subject j is denoted by C
(j)
i . Note that X
(j)’s are
observed but the subject subgroup and cell type indicators need to be estimated.
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2.1 The Dirichlet Process
The DP (Ferguson, 1973) can be understood as a generalized version of the finite mixture
model. For notation simplicity, we temporarily only consider the data on cells from subject
1 and let the gene number G be one, thus the column vectors X
(1)
1 , . . . ,X
(1)
n1 of X
(1) can be
simplified to univariate samples X1, . . . , Xn1 and the cell type indicators C
(1)
i ’s to Ci’s. The
finite mixture model allocates each cell to one of K cell types with a probability to cell type k
being pik, i.e., Pr(Ci = k) = pik, and
∑K
k=1 pik = 1. Given that cell i is assigned to cell type
k, Xi is assumed to be from the distribution f(x|µk), where f is a probability density (or
mass) function which will be specified in the next section, and µk is a parameter describing
the cell-type-k effect. Usually, the total cell type number K is unknown to data analysts, and
it is challenging to accurately estimate the value of K. The DP overcomes the challenge by
generalizing K to infinity and allowing finite non-empty components, hence not requiring a
prespecification of K.
The construction of the DP is realized by the stick-breaking process (Sethuraman, 1991).
Imagine that we have a stick with length one and we are going to break this stick into infinite
pieces. We first sample a value ψ1 from the beta distribution Beta(1, α) (α > 0) and then cut
the stick at the place ψ1 away from the stick’s left endpoint. Accordingly, the pi1(:= ψ1)-long
piece is kept, and we continue to break the remaining stick with length 1− pi1. Once again, we
generate a value ψ2 from Beta(1, α), cut off ψ2 proportion of the 1−pi1-long stick, and obtain a
new piece with length pi2 := (1−pi1)ψ2. Repeating the breaking procedure on the stick, we have
an infinite number of pieces with kth piece’s length pik := (1−
∑k−1
i=1 pii) · ψk (ψk ∼ Beta(1, α)).
Each piece k is further given a mark (parameter) µk sampled from a distribution H. In this
way, we construct a probability measure, P =
∑∞
k=1 pikδµk (δµ indicates the Dirac measure at
µ), with infinite weights {pik}∞k=1 and the support on infinite atoms {µk}∞k=1. The measure
P is said to be from a DP with the concentration parameter α and the base distribution H,
written as P ∼ DP(α,H). Under P , each cell i has the probability pik to be from cell type k
for any positive integer k without a constraint K.
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2.2 The Hierarchical Dirichlet Process and the Nested Dirichlet
Process
The DP is only applicable for one level clustering. When another subject level exists, the
HDP (Teh et al., 2006) aims to cluster cells for each subject and is able to match cell types in
different subjects. In other words, if the cell type indicators C
(j1)
i1
and C
(j2)
i2
are equal (j1 may
not be j2), then the cell i1 in subject j1 and the cell i2 in subject j2 must be from the same cell
type. Assume G(j) is the subject-j-specific distribution having a form
∑∞
k=1 pi
(j)
k δµ(j)k
, based on
which the cells in subject j are clustered. To encourage a common support set across G(j)’s,
HDP adopts a hierarchy structure. G0 ∼ DP(α,H) at the higher level and G(j)’s are then
i.i.d. generated from DP(γ,G0) at the lower level. Since the G0 from DP(α,H) is a discrete
distribution and it plays the role of the base distribution in DP(γ,G0), the atoms µ
(j)
k ’s of the
support of G(j) must be consistent with those of G0. This characteristic guarantees the shared
cell types across G(j)’s in HDP.
Nevertheless, in HDP, any two subjects have distinct cell distributions due to different
weights (cell proportions), i.e., Pr(G(j1) = G(j2)) = 0 if j1 6= j2, thus no group structure exists
among subjects (Figure 2(a)). The NDP (Rodriguez et al., 2008) permits subject grouping
while clustering cells. This ability of NDP is achieved by replacing the base measure G0 in
DP(γ,G0) with a Dirichlet process DP(α,H), written as DP(γ,DP(α,H)). Specifically, if we
let Q = DP(γ,DP(α,H)), Q takes the form of
∑∞
k=1 φkδG∗k , where the atoms of Q are not
numerical values but the distributions G∗k’s from DP(α,H). Subsequently, G
(j)’s are i.i.d.
sampled from Q and Pr(G(j) = G∗k) = φk. Rodriguez et al. (2008) shows that there is a
positive probability that two distributions G(j1) and G(j2) are identical, thus inducing group
structures for G(j)’s, see Figure 2(b). Despite the simultaneous clustering on subjects and cells
enjoyed by NDP, its assumed continuous measure H leads to totally distinct supports between
two subject subgroups, see Figure 2(b). Two subjects’ distributions from NDP either share
the support atoms and cell proportions or do not have any common atom or cell proportion,
hence causing difficulty in cell-type-matching for two different subject subgroups.
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Figure 2: The simple demonstrations of three nonparametric Bayesian priors, HDP, NDP, and
our prior. (a) HDP can make subject-specific distributions G(1), G(2), G(3) and G(4) share the
distribution support. However, each distribution G(k) has completely different bar heights
(weights) from another, so HDP does not induce the subject subgroup structure. (b) NDP can
achieve the subject subgroup structures, but two distributions in different subgroups do not
have the same support, making it hard to match cell types across subgroups. (c) Our prior
not only groups subject-specific distributions but also enables cell-type-matching between any
two subject subgroups.
3 The SCSC Model
We hybridize HDP and NDP into a new nonparametric prior, that succeeds in promoting
subject subgroups with shared cell types. The nonparametric prior is constructed by assigning
a DP prior to the base measure in the NDP,
G0 ∼ DP(α,H),
G(j)(j = 1, . . . ,m)
i.i.d.∼ DP(ν,DP(γ,G0)). (3.1)
9
Table 1: Comparing the capabilities of the HDP, the NDP and our prior.
Prior Subject subgroup structures Shared support
HDP × √
NDP
√ ×
Our prior
√ √
On the one hand, since G0 is drawn from DP(α,H), it has a countable support set. This
property of G0 makes the child distributions G
(j)’s share the same support, thus enabling the
cell-type-matching across subjects, an important function not favored by NDP. On the other
hand, given G0, the NDP DP(ν,DP(γ,G0)) helps to form subgroups for subjects. Therefore,
the hierarchical and nested nonparametric prior (3.1) integrates the strengths of HDP and
NDP, see Figure 2(c) and Table 1.
Next, we tailor a zero-inflated distribution to the scRNA-seq raw count data and connect
the data-modeling part to the proposed nonparametric prior at the final step. We assume that
Y
(j)
gi is the true read count mapped to gene g in cell i for subject j, but Y
(j)
gi ’s are only partially
observed through the collected data X
(j)
gi ’s due to the dropout events. Since the probability of
happening the dropout relies on the value of Y
(j)
gi ’s, i.e., the larger the Y
(j)
gi the less likely that
we observe a zero value, the dropout mechanism is “nonignorable” using the terminology in
the field of missing data analysis,
X
(j)
gi =
 0 with probability p(Y
(j)
gi )
Y
(j)
gi with probability 1− p(Y (j)gi ).
The dropout rate p(y) is modeled as Φ(λg0 + λg1 log2(y + 1)) via a Probit link, in which
λg1 < 0 and Φ is the cumulative distribution function of the standard normal distribution.
The negative λg1 guarantees the negative correlation between y and p(y), and its dependence
on the gene index g accurately models the biological observations that the dropout rate may
be associated with the gene’s features, such as the gene length (Liu et al., 2019), GC contents.
Due to the count nature and over-dispersion of scRNA-seq data, we adopt the Poisson-log-
normal (PLN) distribution for the variable Y
(j)
gi . The PLN distribution has two parameters η
and σ2, corresponding to the mean and variance of the logarithmic Poisson rate, respectively.
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Mathematically, Y ∼ PLN(η, σ2) if and only if Y ∼ Poi(eθ), θ ∼ N(η, σ2). This equivalence
implies that PLN accounts for the over-dispersion (Supplementary Section S1). Note that
the cell’s library size is also a factor affecting the magnitude of the read count. We model
Y
(j)
gi using Y
(j)
gi ∼ Poi(s(j)i eθ
(j)
gi ) and θ
(j)
gi ∼ N(η(j)gi , σ2g), written as Y (j)gi ∼ PLN(s(j)i , η(j)gi , σ2g) for
simplicity, where s
(j)
i is a scaling factor to consider cells’ different library sizes. Specifically, if
we denote the library size of cell i in subject j by l
(j)
i , s
(j)
i is calculated as l
(j)
i /mediani l
(j)
i ,
and in practice we let l
(j)
i be
∑G
g=1X
(j)
gi . The η
(j)
gi represents the effects on gene g caused by
cell i and subject j, and σ2g reflects the variation. We separate cell effects from subject effects
and let η
(j)
gi be the addition of the cell-specific effect µ
(j)
gi and the subject-specific effect β
(j)
g .
Combining the dropout mechanism and the PLN distribution for Y
(j)
gi ’s gives the zero-
inflated PLN (ZIPLN) distribution for the observed data X
(j)
gi ’s, which we write as X
(j)
gi ∼
ZIPLN(λg0, λg1, s
(j)
i , µ
(j)
gi + β
(j)
g , σ2g). We notice that Y
(j)
gi is from a count-valued distribution
with a positive probability at zero, so X
(j)
gi = 0 results from either Y
(j)
gi = 0 or Y
(j)
gi > 0 with
a dropout. Hence, dropout events hide themselves among observed zeros and we are not
clear which portion of zeros are truly from the dropout, which brings us more difficulty than
analyzing the missing data where we know which part is missing.
Lastly, we assign the nonparametric prior (3.1) to the cell-specific effect vector µ
(j)
i =
(µ
(j)
1i , . . . , µ
(j)
Gi ), arriving at the following SCSC (Subject and Cell clustering for Single Cell
expression data) model,
G0 ∼ DP(α,H),
G(j)(j = 1, . . . ,m)
i.i.d.∼ DP(ν,DP(γ,G0)),
µ
(j)
i (i = 1, . . . , nj)
i.i.d.∼ G(j) for each j,
X
(j)
gi ∼ ZIPLN(λg0, λg1, s(j)i , µ(j)gi + β(j)g , σ2g) for each j, i, and g. (3.2)
We constrain the subject-specific effects β
(j1)
g = β
(j2)
g for any g if G(j1) = G(j2), as subjects
from a subgroup usually exhibit the same characteristic. Moreover, to make the parameters
µ and β estimable, we let one subject subgroup act as the “reference” group, for example
the normal group in biomedical studies, and constrain the subject effects β(j) of the reference
group to be zero.
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When there are covariates available for cells or subjects, such as batch information for
cells or clinical records (e.g., age, gender) for subjects, all of the information can be easily
incorporated into the SCSC model by treating them as additive effects on µ
(j)
gi + β
(j)
g in the
ZIPLN distribution. In this way, the SCSC not only detects the heterogeneity among subjects
and cells but also estimates how these covariates influence gene expression from the perspective
of both subjects and cells.
We acknowledge that other types of count-valued distributions considering the over-
dispersion can be used here, for example, the negative-binomial distribution (Risso et al.,
2018). SCSC serves as a flexible framework to choose the appropriate sampling distribution
depending on the researchers and the problem contexts. We focus on the PLN distribution in
the paper mainly for its relative computational convenience.
On the one hand, SCSC has the advantage of simultaneously grouping subjects, clustering
cells, and obtaining consistent cell types across subject groups (Figure 2(c)). More importantly,
with the benefit of the nonparametric prior (3.1), we do not need to determine the subtype
number and the cell type number in advance, both of which can be automatically learned from
data. On the other hand, SCSC is carefully designed to account for the count nature, the
dropout, the over-dispersion, and the library size of the scRNA-seq data. Therefore, SCSC can
be directly applied to the raw count scRNA-seq data without the need of the normalization
and avoids the risk of obtaining different results using different normalization strategies.
4 Bayesian Inference
The exact posterior sampling for the SCSC model can be carried out by the Polya-urn scheme
(Pitman, 1996) that marginalizes all the distributions G0 and G
(j)’s (j ≥ 1). However, the
marginalization procedure introduces extra dependence among cells and causes the cell-type
allocation update for one cell to rely on all other cells. Such a sequential update scheme results
in unnecessary and heavy computations. To enhance the posterior sampling efficiency for the
SCSC model, we utilize the blocked Gibbs sampler (Ishwaran and James, 2001), where the
updates in each parameter block are independent, by taking a truncation strategy (Ishwaran
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and James, 2001; Rodriguez et al., 2008)—setting the upper bounds L for the number of
subject subgroups and K for the cell type number. Moreover, the blocked Gibbs sampler also
favors the employment of the parallel computing to further speed up the Bayesian computation.
The truncated version of SCSC is
G0 ∼ DP(α,H),
G(j)(j = 1, . . . ,m)
i.i.d.∼ DPL(ν,DPK(γ,G0)),
µ
(j)
i (i = 1, . . . , nj)
i.i.d.∼ G(j) for each j,
X
(j)
gi ∼ ZIPLN(λg0, λg1, s(j)i , µ(j)gi + β(j)g , σ2g) for each j, i, and g. (4.1)
Using the stick-breaking process metaphor, DPK(γ,G0) indicates we break the unit stick
into K pieces rather than infinite pieces. The following theorem states that the truncation
Model (4.1) is an accurate approximation to the original Model (3.2) as long as the truncation
numbers L and K as well as concentration parameters γ and ν are approximately chosen. See
the Supplementary Section S2 for the proof, which is based on the Theorem B1 in the NDP
paper (Rodriguez et al., 2008).
Theorem 1. Denote the prior distributions of cell effects µ from the SCSC model and the
truncated SCSC model by p∞∞(µ) and pKL(µ), respectively. Based on the priors, we have the
marginal distributions p∞∞(x) and pKL(x) for the observed data x by integrating all parameters
out. It shows that
1
4
∫ ∣∣pKL(x)− p∞∞(x)∣∣ dx ≤ 1− [1− ( ν
ν + 1
)L−1]m [
1−
(
γ
γ + 1
)K−1] m∑
j=1
nj
.
If we expand the implicit distributions G(j)’s in Model (4.1) in terms of subject cluster
indicators S(j)’s and cell type indicators C
(j)
i ’s, then Model (4.1) implies a more concrete and
interpretable model.
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ξ = (ξ1, ξ2, . . . , ξK) ∼ GEMK(α),
µk (k = 1, . . . , K)
i.i.d.∼ H,
pi` = (pi1`, . . . , piK`) (` = 1, . . . , L)
i.i.d.∼ Dir(γξ1, γξ2, . . . , γξK)
φ = (φ1, φ2, . . . , φL) ∼ GEML(ν),
S(j) (j = 1, . . . ,m)
i.i.d.∼ MN(1;φ1, φ2, . . . , φL),
C
(j)
i (i = 1, . . . , nj)|S(j) = ` i.i.d.∼ MN(1; pi1`, . . . , piK`) for each j,
X
(j)
gi |S(j) = `, C(j)i = k ∼ ZIPLN(λg0, λg1, s(j)i , µgk + βg`, σ2g) for each j, i, and g.
(4.2)
MN is the multinomial distribution and Dir indicates the Dirichlet distribution. GEML(ν)
refers to the truncated stick-breaking process in which the stick proportions {φ′1, φ′2, . . . , φ′L−1}
are i.i.d. from Beta(1, ν) and φ1 = φ
′
1, φ` = φ
′
`
∏`−1
t=1(1 − φ′t) for 2 ≤ ` ≤ L − 1, and
φL = 1−
∑L−1
`=1 φ`. The same spirit is for GEMK(α). Once again, we note that the subgroup
one effect vector β1 is fixed at zero for identifiability.
We prove Model (4.2) is equivalent to Model (4.1) in Appendix. From now on, we focus on
Model (4.2) to carry out the Bayesian inference.
Next, we specify the priors for unknown parameters in Model (4.2). The priors for
concentration parameter α (α > 0) is flat, p(α) ∝ 1. Regarding the baseline distribution H of
cell-type-k effects µgk’s, it is set as the Cartesian product of G normal distributions N(ηµ, τ
2
µ),
and we assign priors p(ηµ) ∝ 1 and p(τ 2µ) ∝ 1τµ to ηµ and τ 2µ , respectively. Similarly, we assign a
normal distribution N(ηβ, τ
2
β) to the subtype effect βg` and further give ηβ and τ
2
β hyper-priors
p(ηβ) ∝ 1 and p(τ 2β) ∝ 1τβ to introduce hierarchy for subject effects, so the information can be
borrowed across genes. The variance σ2g ’s prior distribution is an inverse-gamma distribution
p(σ2g) ∝ 1/σ2g , and the priors for zero-inflation-related parameters λg0 and λg1 are given by
weakly informative priors N(ηλg0 , τ
2
λg0
) and N(ηλg1 , τ
2
λg1
), respectively.
Finally, given the priors and Model (4.2), we utilize the blocked Gibbs sampler (Ishwaran
and James, 2001) to carry out the posterior sampling. Since directly sampling from ZIPLN
distribution suffers from intractable infinite sum and integral, we augment the auxiliary
variables θ
(j)
gi and Y
(j)
gi (Tanner and Wong, 1987) specified in Section 3 to make the sampling
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for ZIPLN feasible. Accordingly, in each iteration, the sampling scheme proceeds as follows.
(“−” means given all other variables)
1 The augmented parameter θ
(j)
gi in the PLN distribution is generated from
p(θ
(j)
gi |−) ∝ exp
{
−s(j)i eθ
(j)
gi + Y
(j)
gi θ
(j)
gi −
(θ
(j)
gi − µgk − βg`)2
2σ2g
}
,
when S(j) = ` and C
(j)
i = k.
2 Sample the missing variable Y
(j)
gi for which its observation X
(j)
gi equals zero from
p(Y
(j)
gi |−) ∝
 (s
(j)
i e
θ
(j)
gi )Y
(j)
gi /Y
(j)
gi ! · Φ(λg0 + λg1 log2(Y (j)gi + 1)), if Y (j)gi ≥ 1
1, if Y
(j)
gi = 0.
3 Update the zero-inflation intensity parameters λg0 and λg1 by generating
(λg0, λg1) ∼ p(λg0, λg1|−) ∝
∏
(j,i):X
(j)
gi >0
(
1− Φ(λg0 + λg1 log2(Y (j)gi + 1))
)
·
∏
(j,i):X
(j)
gi =0,Y
(j)
gi >0
Φ
(
λg0 + λg1 log2(Y
(j)
gi + 1)
)
· N(λg0; ηλg0 , τ 2λg0) · N(λg1; ηλg1 , τ 2λg1).
The N(x; a, b2) represents the density value at x of a normal distribution with mean a
and standard deviation b.
4 Sample the cell-type k effect on gene g, µgk, from the normal distribution
N

m∑
j=1
nj∑
i=1
(θ
(j)
gi − βgS(j))I(C(j)i = k)/σ2g + ηµ/τ 2µ
m∑
j=1
nj∑
i=1
I(C
(j)
i = k)/σ
2
g + 1/τ
2
µ
,
1
m∑
j=1
nj∑
i=1
I(C
(j)
i = k)/σ
2
g + 1/τ
2
µ
 ,
where the I(A) is an indicator function, being one if A is true and zero otherwise.
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5 Update the hyper-parameters in the cell-type effect prior,
p(ηµ|−) ∝ N
(
G∑
g=1
K∑
k=1
µgk/GK, τ
2
µ/GK
)
,
p(τ 2µ|−) ∝ InvΓ
(
(GK − 1)/2,
G∑
g=1
K∑
k=1
(µgk − ηµ)2/2
)
.
6 The subgroup ` effect on gene g for ` ≥ 2, βg`, is sampled from the normal distribution
N

m∑
j=1
nj∑
i=1
(θ
(j)
gi − µgC(j)i )I(S
(j) = `)/σ2g + ηβ/τ
2
β
m∑
j=1
I(S(j) = `)nj/σ2g + 1/τ
2
β
,
1
m∑
j=1
I(S(j) = `)nj/σ2g + 1/τ
2
β
 .
We notice that subgroup 1 effect, βg1, is restricted to zero across 1 ≤ g ≤ G for
identifying the subgroup and cell-type effects.
7 Update the hyper-parameters in the subgroup effect prior,
p(ηβ|−) ∝ N
(
G∑
g=1
L∑
`=2
βg`/G(L− 1), τ 2β/G(L− 1)
)
,
p(τ 2β |−) ∝ InvΓ
(
(GL−G− 1)/2,
G∑
g=1
L∑
`=2
(βg` − ηβ)2/2
)
.
8 Update the variance σ2g for gene g by sampling from the inverse-gamma distribution
InvΓ(
m∑
j=1
nj/2,
m∑
j=1
nj∑
i=1
(θ
(j)
gi − µgC(j)i − βgS(j))
2/2).
9 For each subject j, update the subtype indicator S(j) and the cell-type indicators C
(j)
i
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for cell i = 1, . . . , nj from multinomial distributions
P (S(j) = `|−) ∝ φ`
nj∏
i=1
[
K∑
k=1
pik`
G∏
g=1
N(θ
(j)
gi ;µgk + βg`, σ
2
g)
]
P (C
(j)
i = k|S(j) = `,−) ∝ pik`
G∏
g=1
N(θ
(j)
gi ;µgk + βg`, σ
2
g),
` = 1, . . . , L and k = 1, . . . , K.
10 Update the subtype proportion vector (φ1, φ2, . . . , φL). We first sample
φ′` ∼ Beta(1 +m`, ν +
L∑
j=`+1
mj)
for ` = 1, . . . , L− 1 and φ′L := 1, where m` = #{j : S(j) = `} is the number of subjects
allocated to subgroup `. Subsequently, we let φ1 = φ
′
1 and φ` = φ
′
`
∏`−1
i=1(1 − φ′i) for
` = 2, . . . , L.
11 Update the stick-breaking length vector (ξ1, ξ2, . . . , ξK). We first sample
p((ξ′1, . . . , ξ
′
K−1)|−) ∝
∏K−1
k=1 (1− ξ′k)α−1∏K
k=1 Γ
L(γ
∏k−1
i=1 (1− ξ′i)ξ′k)
K∏
k=1
(
L∏
`=1
pik`
)γ∏k−1i=1 (1−ξ′i)ξ′k−1
.
and ξ′K := 1. Subsequently, we let ξ1 = ξ
′
1 and ξk =
∏k−1
i=1 (1− ξ′i)ξ′k for k = 2, . . . , K.
12 The concentration parameter α is sampled from the gamma distribution
p(α|−) ∼ Γ
(
K,−
K−1∑
k=1
log(1− ξ′k)
)
,
where and ξ′ks are the variables generated in the previous iteration.
13 Sample the cell type proportions (pi1`, . . . , piK`) for each subtype ` from the Dirichlet
distribution
Dir(
m∑
j=1
nj∑
i=1
I(S(j) = `, C
(j)
i = 1) + γξ1, . . . ,
m∑
j=1
nj∑
i=1
I(S(j) = `, C
(j)
i = K) + γξK).
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For steps 1, 2, 3, and 11 of the blocked Gibbs sampler, they do not correspond to
standard distributions, so we design the Metropolis-Hastings (MH) steps to approximate the
sampling. The proposal distributions and the calculations of acceptance rates are relegated to
Supplementary Section S3. Within each iteration the computational complexity is O(G(K +
L)
∑m
j=1 nj), which increases linearly with the gene number, the subject number, and the cell
number. Therefore, our MCMC algorithm can scale well on a large volume of scRNA-seq data.
After the burn-in period which is defined as the first half of iterations, we collect the
posterior samples from the last half of iterations for statistical inference. For subtype and
cell-type indicators, S(j)’s and C
(j)
i ’s, we adopt the mode of the posterior samples to estimate
them to keep the integer nature. For the subgroup effects and cell-type-specific effects βg`’s
and µgk’s, the posterior mean is used for estimation.
5 Results
5.1 Simulation
We generated the data following Model (4.2) with three subject subgroups and four cell types.
The subject size was chosen as 50, and for each subject we sampled its corresponding cell
number from a uniform distribution on integers between 15 and 35. The subject proportion
for the three subgroups were 40%, 30%, 30%. For each subject subgroup, we had different
cell type proportions pi` (` = 1, 2, 3). Subject subgroup 1 has 20%, 30%, 30%, 20% for cell
types from one to four, respectively. If we denote that as pi1 = (0.2, 0.3, 0.3, 0.2), then we set
pi2 = (0.4, 0.2, 0.3, 0.1) for subject subgroup 2 and pi3 = (0.3, 0.1, 0.3, 0.3) for subject subgroup
3. The gene number for each cell was 1, 000, and the first 200 genes were treated as marker
genes which are differentially expressed in at least two cell types, whereas the remaining genes
had the same cell effects across all cell types. With regard to the subject subgroup effects,
the subject subgroup 1 effects were fixed at zero. Using the subgroup 1 as the reference, the
subgroup 2 had marker genes from 401 to 500, and the subgroup 3 had marker genes from
501 to 600. The generation procedure for the cell type effects and the subgroup effects is
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detailed in Supplementary Section S4. The scaling factors were fixed at one. The dropout
coefficients λg0 and λg1 were sampled respectively from N(3, 0.1
2) and N(−1, 0.12), and the
standard deviations σg’s were fixed at 0.1.
We then applied our SCSC model to this dataset using the subject subgroup upper bound
L = 10, the cell type number upper bound K = 10, and γ = ν = 0.1, which guarantees a
very small approximation error 2.2× 10−6 based on Theorem 1. We carried out T = 10, 000
iterations, which cost about 61.68 minutes using 10 CPU cores, and kept the second half of
posterior samples for statistical inference. The trace plots of parameters in Supplementary
Figure S1 demonstrated the chain had attained convergence by 5,000th iteration. For the
number of the occupied subject clusters, its posterior mode is three, and the posterior mode
of the occupied cell types is four, both of which are the same as the truth. To measure the
clustering accuracy, we used the adjusted random index (ARI) (Hubert and Arabie, 1985),
which is bounded above by one, and the larger the ARI, the more accurate the clustering
results. It turns out SCSC gave a perfect clustering for subjects as well as cells with both
ARIs being one, see Figure 3(e-g). Hence, the SCSC model can automatically and accurately
distinguish the underlying heterogeneity for subjects and cells.
By correcting the label-switching, we evaluated the estimates of SCSC for the cell type
effects µ and the subgroup effects β. The Figure 3(a-d) shows the comparison between the
true parameter values and the estimates, indicating that the SCSC model estimated the two
types of effects well. With the available posterior samples of µ and β, we further detected the
DE genes across cell types or subject subgroups using Bayesian credible intervals. For example,
if we test whether gene g is DE between cell type 1 and cell type k (k ≥ 2), we constructed the
99% credible interval for the difference µgk − µg1 using the posterior samples. If zero is not in
this credible interval, then we treat the gene as DE. Otherwise, the gene is non-DE. Although
we conducted multiple hypothesis testings, we do not need to implement multiple comparison
adjustments as µ and β were modeled in a hierarchical Bayesian fashion (Gelman et al., 2012).
The similar procedure was applied to detecting DE genes across subject subgroups. It turns
out that SCSC correctly detected most of DE genes with high power and small false positive
rates as shown in Supplementary Table S1.
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Figure 3: The performance of the SCSC model in the simulation study. (a) The heatmap of
the true cell effects µgk’s and (b) the heatmap of cell effect estimations. In both (a) and (b),
one row is one gene and each column represents one cell type. (c) The heatmap of the true
subject subgroup effects and (d) the heatmap of subject subgroup effect estimations. In both
(c) and (d), one row is one gene and each column represents one subject subgroup. (e-g) The
scatter plots of the cells after the dimension reduction with two UMAP components in subject
subgroup 1, 2, and 3, respectively.
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Cell clustering comparison(a) Subject clustering comparison(b)
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Figure 4: The clustering performances of the SCSC model as well as competing methods in
the cell clustering and the subject clustering settings based on ten realizations. (a) The ARI
box plots for SCSC and other cell clustering approaches. (b) The ARI box plots for SCSC and
other subject clustering approaches. The implementation details of the competing methods
are provided in the Supplementary Section S5.
Since there is no statistical approach to simultaneously cluster subjects and cells, we
compared SCSC against some popular cell clustering approaches and subject clustering
approaches, respectively. For the cell clustering approaches Kmeans (MacQueen et al., 1967),
SC3 (Kiselev et al., 2017), DIMM-SC (Sun et al., 2017), Seurat (Butler et al., 2018; Stuart
et al., 2018), we stacked the expression matrices for all subjects by row and used this large
expression matrix as the input. With regard to the subject clustering approaches Kmeans
(MacQueen et al., 1967), SparseKmeans (Witten and Tibshirani, 2010) and BCPlaid (Turner
et al., 2005), we calculated the row means of its corresponding expression matrix (logarithm
transformed) for each subject and combined all row means to form a gene by subject aggregated
expression matrix. The Figure 4 displays the boxplots for ARI values of all methods under the
cell clustering setting and the subject clustering setting based on ten realizations. Overall,
SCSC performed the best in both cell clustering and subject clustering. When clustering
cells, SCSC borrows information across multiple subjects and considers the subject differences.
When grouping subjects, SCSC takes advantage of the cell information of each subject to
discover the subtle difference. Thanks to the two-way information-sharing strategy, SCSC
outperforms competing methods in both cell clustering and subject grouping.
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5.2 Real Application
Sarkar et al. (2019) collected scRNA-seq datasets from 7585 induced pluripotent stem cells
(iPSCs) in a total of 54 Yoruba subjects in Nigeria. The datasets are publicly available with
the accession code GSE118723 in GEO (Edgar et al., 2002). Although the purpose of the
study (Sarkar et al., 2019) is to detect variance QTLs, we can use the same dataset to mine
out other interesting information, such as the cell and subject heterogeneity presented here.
At the subject level, Yoruba is one of Nigeria’s largest ethic groups, and Yoruba people in
the same lineage are more likely to have similar social habits, political preferences (Schwab,
1955) or to suffer from the same genetic diseases (Olaitan et al., 2014). Therefore, analyzing
the heterogeneity of the Yoruba people can help clarify their family relationships or even find
Yoruba sub-races. At the cell level, the iPSCs are reprogrammed from the somatic cells in adult
tissues and have the ability to differentiate into many cell types, so they can be potentially
used to make personalized treatments for patients. The iPSCs derived from different somatic
cell types may demonstrate heterogeneous differentiation abilities (Kim et al., 2011). Our
aim is to apply SCSC to the dataset to distinguish Yoruba individuals and separate the iPSC
heterogeneity at the same time.
Our analysis focused on scRNA-seq counts from batch 6 in their study, which includes 20
subjects and 1152 cells. In the preprocessing procedure, we filtered out cells with the zero
proportion more than 80% and genes with the zero proportion more than 30%, and further
removed subjects having less than 5 cells, resulting in a scRNA-seq dataset with 14 subjects,
1028 cells, and 4178 genes. The cell numbers of the selected 14 subjects range from 29 to 129.
During the analysis, the scaling factors for each cells were computed to adjust the effects of
library sizes.
We next carried out the SCSC model with the subject subgroup upper bound 10 and the
cell type upper bound 10. The blocked Gibbs sampler proceeded 10,000 iterations with the
first half as the burn-in period, and it took about 4.63 hours using 10 CPU cores. The trace
plots in Supplementary Figure S2 showed that the chains had attained convergence during
burn-in. Two Yoruba subgroups and two iPSC types were identified. Yoruba subgroup 1
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Heatmap for cells in subject subgroup 1 (a) Heatmap for cells in subject subgroup 2(b)
(c) UMAP plot for cells in subject subgroup 1 (d) UMAP plot for cells in subject subgroup 2
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Figure 5: The performance of SCSC on the Yoruba iPSC scRNA-seq data. (a) The heatmap for
the logarithm-transformed and row-scaled gene expression values of cells in subject subgroup
1, where each row corresponds to one detected DE gene between the two cell types and each
column represents a cell. There are 2662 DE genes, 35 type 1 cells, and 141 type 2 cells. Cells
under the same color are from the same cell type. (b) The heatmap for logarithm-transformed
and row-scaled gene expression values of cells in subject subgroup 2. Rows and columns have
the same meaning as those of the previous heatmap. There are 2662 DE genes, 162 type 1
cells, and 690 type 2 cells. (c-f) The scatter plots by projecting cells in subject subgroups 1
and 2 to a two dimensional space using UMAP. Cells are colored by the estimated cell types:
cell type 1 (orange), cell type 2 (green).
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contains two subjects and have cellular compositions 19.89%, 80.11% for cell types 1 and
2. Subgroup 2 Yoruba contains twelve subjects with cell type compositions 19.01%, 80.99%.
The Figure 5(a) and 5(b) showed the heatmaps for logarithm transformed and row scaled
expression values in Yoruba subgroups 1 and 2, respectively. We observed obviously differential
expression patterns between cell types 1 and 2 on detected cell type DE genes, indicating there
indeed exists heterogeneity among iPSCs. Besides the cellular compositions, the estimated
effects of the Yoruba subgroups also demonstrated the heterogeneity of the Yoruba individuals
(Supplementary Figure 3). The cells in each Yoruba subgroup were projected into a two-
dimensional UMAP scatter plot using the R package umap (Konopka, 2019). Figure 5(c-d)
show a clear cell pattern in Yoruba subgroups 1-2: cells of type 1 (orange) and type 2 (green)
are well-separated.
To validate the clustering results, we conducted the gene set enrichment analysis (Subra-
manian et al., 2005) for detected marker genes based on the KEGG database. The maker
genes for Yoruba subgroups or iPSC types were called if they are DE in at least one sub-
group or cell type, respectively. We identified 602 intrinsic genes between the Yoruba sub-
groups and found 40 significant pathways with q-value < 0.05 (Supplementary Table S2),
where three pathways KEGG PARKINSONS DISEASE, KEGG HUNTINGTONS DISEASE,
and KEGG ALZHEIMERS DISEASE are all related to neurodegenerative disorders. Pre-
vious studies (Myers, 2004; Bertram and Tanzi, 2008; Shulman et al., 2011) have pre-
sented that the three diseases are likely caused by inheritable gene defects and thus can
be inherited from one generation to the next. The observations reflect that SCSC sep-
arated the Yoruba subjects possibly in terms of the lineage. In addition, we detected
2662 DE genes across the cell types and identified 74 significant pathways (Supplemen-
tary Table S3 and S4) including KEGG RIBOSOME, KEGG P53 SIGNALING PATHWAY,
KEGG WNT SIGNALING PATHWAY, KEGG NOTCH SIGNALING PATHWAY, and
KEGG MTOR SIGNALING PATHWAY. Since the ribosomes play a critical role in the trans-
lation process from mRNAs to proteins, the two iPSC types may have differences in genes
related to ribosome generation. In addition, the four signaling pathways may regulate the
pluripotency of induced stem cells (Ye et al., 2012; Kate et al., 2014; Meng et al., 2018). These
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findings indicate the validity of the SCSC in discovering subject and cell heterogeneity.
6 Conclusion
We develop a nonparametric Bayesian model SCSC to simultaneously discover subject and cell
heterogeneity in a two-level clustering way. SCSC has the flexibility of learning the subject
subgroup number or the cell type number by data without a prespecification. Different from
the priors HDP or NDP, we proposed the nonparametric Bayesian prior of SCSC to induce
group structures in subjects, cluster cells in each subject, and match cell types across subjects.
The ZIPLN distribution employed in SCSC directly models the count nature, over-dispersion,
and dropouts of the scRNA-seq data. Owing to the two features, the SCSC model achieves the
subject-level and cell-level clustering on the multi-subject scRNA-seq data. When clustering
subjects, SCSC takes advantage of the cell-resolution differences; and when clustering cells,
SCSC borrows information across multiple subjects. The two-way information-sharing strategy
enables SCSC to obtain more accurate clustering results than competing methods in the
domain of either subject clustering using bulk expression data or cell clustering based on
scRNA-seq data.
To the best of our knowledge, SCSC is the first unified approach to addressing the two-level
clustering for scRNA-seq data. Especially, SCSC bridges the methodology gap between the
subject clustering based on aggregated gene expression data and the scRNA-seq cell clustering.
The framework in SCSC can be further adapted to any situations where the observed data
are sparse, count-valued and the two-level clustering are of interest. For example, in the text
mining context, a topic can be treated as a subject, a document represents a cell, and the word
dictionary corresponds to the gene set. The word frequency data are also count and highly
sparse. Thus, SCSC can be applied to finding the topic groups as well as document clusters.
With the continuous progress of the sequencing technology, the single cell RNA sequencing will
be affordable and available for more and more people. Therefore, we envision that the SCSC
model can be a useful method to facilitate the development of the personalized treatment in
the time of single cell genomics.
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Appendix
We prove that Model (4.2) is equivalent to Model (4.1).
Proof. In Model (4.1), we first focus on the first three lines,

G0 ∼ DP(α,H)
G(j)|G0 ∼ DPL(ν,DPK(γ,G0))
µ
(j)
i |G(j) ∼ G(j)
⇐⇒ (∗)

G0 ∼ DP(α,H)
G∗` |G0 ∼ DPK(γ,G0) for 1 ≤ ` ≤ L
φ = (φ1, φ2, . . . , φL) ∼ GEML(ν)
G(j)|G∗` ,φ ∼
∑L
`=1 φ`δG∗`
µ
(j)
i |G(j) ∼ G(j).
Note that G0 ∼ DP(α,H) and G∗′` |G0 ∼ DP(γ,G0) are equivalent to ρ = (ρ1, ρ2, . . .) ∼
GEM(α), µk ∼ H, pi′` = (pi′1`, pi′2`, . . .)|ρ ∼ DP(γ,ρ) and G∗′` =
∑∞
k=1 pi
′
k`δµk according to the
results from HDP (Teh et al., 2006). Subsequently, when there is a truncation K on the
distribution G∗
′
` =
∑∞
k=1 pi
′
`kδµk , we have G
∗
` =
∑K
k=1 pik`δµk , where pik` = pi
′
k` for 1 ≤ k ≤ K−1
and piK` =
∑∞
i=K pi
′
i`. Therefore, the first two lines of the expression (∗) are
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 G0 ∼ DP(α,H)G∗` |G0 ∼ DPK(γ,G0) ⇐⇒

ρ = (ρ1, ρ2, . . .) ∼ GEM(α)
µk ∼ H
pi` = (pi1,`, . . . , piK−1,`, piK,`)|ρ
∼ Dir(γρ1, . . . , γρK−1, γ
∑∞
i=K ρi)
G∗` |pi`,µk =
∑K
k=1 pik`δµk
⇐⇒

ξ := (ξ1 = ρ1, . . . , ξK−1 = ρK−1, ξK =
∑∞
i=K ρi)
∼ GEMK(α)
µk ∼ H
pi`|ξ ∼ Dir(γξ1, . . . , γξK)
G∗` |pi`,µk ∼
∑K
k=1 pik`δµk .
The second equivalence holds because for any ξ ∼ GEMK(α) we can find a ρ following
GEM(α) by letting ρk = ξk for 1 ≤ k ≤ K − 1, ρK = (1 −
∑K−1
i=1 ρi) · ρ′K , and ρk =
(1−∑K−1i=1 ρi) ·∏k−1i=K(1− ρ′i) · ρ′k for k ≥ K + 1, where ρ′i ∼ Beta(1, α) (i ≥ K); and on the
opposite direction, for any ρ ∼ GEM(α), ξ follows GEMK(α) through the construction above.
Next, we plug the result above into the expression (∗), leading to

G0 ∼ DP(α,H)
G(j)|G0 ∼ DPL(ν,DPK(γ,G0))
µ
(j)
i |G(j) ∼ G(j)
⇐⇒

ξ ∼ GEMK(α)
µk ∼ H
pi`|ξ ∼ Dir(γξ1, . . . , γξK)
G∗` |pi`,µk =
∑K
k=1 pik`δµk
φ = (φ1, φ2, . . . , φL) ∼ GEML(ν)
G(j)|G∗` ,φ ∼
∑L
`=1 φ`δG∗`
µ
(j)
i |G(j) ∼ G(j).
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Considering S(j), C
(j)
i , and the distribution for scRNA-seq data, it follows that

G0 ∼ DP(α,H)
G(j)|G0 ∼ DPL(ν,DPK(γ,G0))
µ
(j)
i |G(j) ∼ G(j)
X
(j)
gi |µ(j)i ∼
ZIPLN(λg0, λg1, s
(j)
i , µ
(j)
gi + β
(j)
g , σ2g)
⇐⇒

ξ ∼ GEMK(α)
µk ∼ H
pi` ∼ Dir(γξ1, . . . , γξK)
φ = (φ1, φ2, . . . , φL) ∼ GEML(ν)
S(j) ∼ MN(1;φ1, φ2, . . . , φL)
C
(j)
i |S(j) = ` ∼ MN(1; pi1`, . . . , piK`)
X
(j)
gi |S(j) = `, C(j)i = k ∼
ZIPLN(λg0, λg1, s
(j)
i , µgk + βg`, σ
2
g).
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